Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasIntellectual disability psychiatry

Psych Vivas · Intellectual disability psychiatry

Psychiatric disorders in intellectual disability — structured clinical viva

Fellowship viva on dual diagnosis: overshadowing, pathoplastic presentation, DC-LD, Cooper epidemiology, Tyrer/Sheehan/Deb psychotropic evidence, adapted therapy.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar in the intellectual disability clinic. Carers of a 28-year-old with moderate ID say new self-injury is 'just the disability'. He has been on risperidone for years for behaviour. Discuss diagnostic overshadowing, modified presentation, DC-LD, hierarchical assessment, and evidence against routine antipsychotics for aggression (Tyrer, Sheehan, Deb). Outline treatment adaptations.

Interpretation

Reveal interpretation

Challenge the frame. Mental ill-health is common in adults with ID (Cooper: clinical ~40%, DC-LD ~35%, lower with standard ICD/DSM). "Just the disability" is diagnostic overshadowing (Reiss) — symptoms of treatable illness attributed to ID.[1][3]

Presentation. In moderate ID, depression/anxiety/psychosis often appear as change from baseline: self-injury, withdrawal, sleep change, unexplained fear, skill loss. Always exclude pain, constipation, dental disease, epilepsy and medication effects first.[2]

DC-LD. Complementary multi-axial criteria for adults with learning disabilities accommodating pathoplasticity and hierarchical diagnosis including problem behaviours versus psychiatric illness.[2]

Medicines. Tyrer 2008: risperidone/haloperidol not superior to placebo for aggressive challenging behaviour. Sheehan 2015: psychotropics prescribed far more often than recorded mental illness. Deb 2009: assess, formulate, non-drug options, clear targets, monitor, review. If continuing or starting medicine: start low, go slow, metabolic/EPS monitoring, time-limited goals, deprescribe when possible. Adapt psychological therapies (simplified CBT/PBS) to ability.[4][5][6]

Close. Multiagency plan, capacity is decision-specific with support, carer education, scheduled review of risperidone indication.[4][6]

Key points

Overshadowing kills quality of care

Change from baseline demands medical and psychiatric work-up, not resignation to the disability label.

DC-LD when pathoplastic

Complementary system when standard criteria under-detect.

Tyrer + Sheehan + Deb

No routine antipsychotics for aggression; overprescribing is real; process-driven prescribing only.
[3] [4] [5] [6]

References

  1. [1]Cooper SA, Smiley E, Morrison J, Williamson A, Allan L Mental ill-health in adults with intellectual disabilities: prevalence and associated factors Br J Psychiatry, 2007.PMID 17197653
  2. [2]Cooper SA, Melville CA, Einfeld SL Psychiatric diagnosis, intellectual disabilities and Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD) J Intellect Disabil Res, 2003.PMID 14516368
  3. [3]Reiss S, Szyszko J Diagnostic overshadowing and professional experience with mentally retarded persons Am J Ment Defic, 1983.PMID 6829617
  4. [4]Sheehan R, Hassiotis A, Walters K, Osborn D, Strydom A, Horsfall L Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study BMJ, 2015.PMID 26330451
  5. [5]Tyrer P, Oliver-Africano PC, Ahmed Z, et al. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial Lancet, 2008.PMID 18177776
  6. [6]Deb S, Kwok H, Bertelli M, et al. International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities World Psychiatry, 2009.PMID 19812757